SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-000367
Filing Date
2024-01-03
Accepted
2024-01-03 16:20:30
Documents
1
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8073
  Complete submission text file 0001209191-24-000367.txt   9615
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O PASSAGE BIO, INC. 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address
Borthwick Kathleen (Reporting) CIK: 0001987062 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39231 | Film No.: 24506754